Condensed Consolidated Statements of Changes in Stockholders' Equity/Member’s Capital and Temporary Equity (Unaudited) - USD ($) $ in Thousands	Total	Redeemable Preferred Units	Class P Units	Common Units	Common Stock	Additional paid-in-capital	Accumulated deficit	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2024		56,619,831	0
Beginning balance at Dec. 31, 2024		$ 68,413	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Redeemable preferred units		$ 2,109
Ending balance (in shares) at Mar. 31, 2025		56,619,831	0
Ending balance at Mar. 31, 2025		$ 70,522	$ 0
Beginning balance (in shares) at Dec. 31, 2024				1,078,929,080
Beginning balance at Dec. 31, 2024	$ 777,918			$ 963,213			$ (184,485)	$ (810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of Redeemable preferred units	(2,109)			$ (2,109)
Foreign currency translation adjustment	485							485
Net loss	(11,729)						(11,729)
Ending balance (in shares) at Mar. 31, 2025				1,078,929,080
Ending balance at Mar. 31, 2025	$ 764,565			$ 961,104			(196,214)	(325)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding (in shares)	0
Beginning balance (in shares) at Dec. 31, 2025	240,956,348	0	240,956,348
Beginning balance at Dec. 31, 2025	$ 143,115	$ 0	$ 143,115
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Redeemable preferred units			$ 192
Reclassification of temporary to permanent equity (in shares)			(240,956,348)		8,885,674
Conversion of Class P Units into shares of common stock	$ 302,113		$ (143,307)		$ 1	$ 302,112
Ending balance (in shares) at Mar. 31, 2026	0
Ending balance at Mar. 31, 2026	$ 0
Beginning balance (in shares) at Dec. 31, 2025	50,000,000			50,000,000
Beginning balance at Dec. 31, 2025	$ 867,824			$ 1,135,910			(269,022)	936
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of Redeemable preferred units	(192)			$ (192)
Deemed dividend on conversion of the Class P Units into shares of common stock	(60,722)					(60,722)
Conversion of common units into shares of common stock (in shares)				(50,000,000)	97,411,398
Conversion of common units into shares of common stock	0			$ (1,135,718)	$ 10	1,135,708
Issuance of common stock in connection with IPO, net of underwriting discounts and commissions and other offering costs (in shares)					18,500,000
Issuance of common stock in connection with IPO, net of underwriting discounts and commissions and other offering costs	583,415				$ 2	583,413
Issuance of common stock for acquisition of Orbion (in shares)					2,812,141
Issuance of common stock for acquisition of Orbion	60,180					60,180
Stock compensation expense	84,696					84,696
Foreign currency translation adjustment	(121)							(121)
Net loss	$ (114,842)						(114,842)
Ending balance (in shares) at Mar. 31, 2026	0
Ending balance at Mar. 31, 2026	$ 1,722,351				$ 13	$ 2,105,387	$ (383,864)	$ 815
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding (in shares)	127,609,213				127,609,213